GAO Report: ICD-10 Stakeholders Concerned Over Testing

Feb. 9, 2015
In what has been a recurring theme, ICD-10 stakeholders are concerned with the testing practices by the Centers for Medicare and Medicaid Services (CMS).
In what has been a recurring theme, ICD-10 stakeholders are concerned with the testing practices by the Centers for Medicare and Medicaid Services (CMS).
The latest findings were revealed in a Government Accountability Office (GAO) report that was produced at the behest of Congressional leaders. The GAO evaluated to see how CMS was preparing providers, payers, and other stakeholders on the transition from ICD-9 to ICD-10. They analyzed responses from 28 stakeholder organizations which participated in CMS meetings regarding ICD-10 in 2013. 
What the GAO found was that stakeholders, of all kinds, were concerned with the thoroughness of CMS’ ICD-10 testing activities, specifically Medicare fee-for-service end-to-end testing. In response, CMS said that it was conducting three rounds of end-to-end testing in 2015 with 2,550 covered entities. Stakeholders are concerned that the number of organizations would not represent all provider types. CMS is attempting to undergo testing at smaller provider facilities as well. CMS also says the number of covered entities that will be tested will exceed the number requested by stakeholder groups.
Another topic of concern for stakeholder groups is educational materials on ICD-10 put out by CMS. The Stakeholders are asking, according to GAO, for more in-person training and additional specialty-specific materials. CMS says it has plans to do this before the Oct. 1, 2015 deadline. The stakeholders are asking CMS to create more awareness on which educational materials are available for stakeholders. They also recommended that CMS do more to engage covered entities through non-electronic methods and to make its Medicare fee-for-service contingency plans public.
A few medical groups are seeking additional delays to ICD-10. There have been two delays thus far. For its part, GAO did not indicate whether or not a delay was necessary. HHS concurred with its recommendations. 

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?